207 related articles for article (PubMed ID: 31893123)
1. Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT
Legros C; Dupré C; Brasseur C; Bonnaud A; Bruno O; Valour D; Shabajee P; Giganti A; Nosjean O; Kenakin TP; Boutin JA
Pharmacol Res Perspect; 2020 Feb; 8(1):e00539. PubMed ID: 31893123
[TBL] [Abstract][Full Text] [Related]
2. New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.
Boutin JA; Bonnaud A; Brasseur C; Bruno O; Lepretre N; Oosting P; Coumailleau S; Delagrange P; Nosjean O; Legros C
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644418
[TBL] [Abstract][Full Text] [Related]
3. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
4. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
[TBL] [Abstract][Full Text] [Related]
5. 17Beta-estradiol modulates hMT1 melatonin receptor function.
Masana MI; Soares JM; Dubocovich ML
Neuroendocrinology; 2005; 81(2):87-95. PubMed ID: 15809517
[TBL] [Abstract][Full Text] [Related]
6. Melatonin MT
López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
[TBL] [Abstract][Full Text] [Related]
7. Docking studies for melatonin receptors.
Alkozi HA; Sánchez Montero JM; Doadrio AL; Pintor J
Expert Opin Drug Discov; 2018 Mar; 13(3):241-248. PubMed ID: 29271261
[TBL] [Abstract][Full Text] [Related]
8. O-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors.
Karamitri A; Sadek MS; Journé AS; Gbahou F; Gerbier R; Osman MB; Habib SAM; Jockers R; Zlotos DP
Bioorg Chem; 2019 Apr; 85():349-356. PubMed ID: 30658234
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
Hu Y; Chan KH; He X; Ho MK; Wong YH
PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
11. Assessments of cellular melatonin receptor signaling pathways: β-arrestin recruitment, receptor internalization, and impedance variations.
Dupré C; Bruno O; Bonnaud A; Giganti A; Nosjean O; Legros C; Boutin JA
Eur J Pharmacol; 2018 Jan; 818():534-544. PubMed ID: 29154938
[TBL] [Abstract][Full Text] [Related]
12. New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.
Ancizu S; Castrillo N; Pérez-Silanes S; Aldana I; Monge A; Delagrange P; Caignard DH; Galiano S
Molecules; 2012 Jun; 17(7):7737-57. PubMed ID: 22732886
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of dual ligands for melatonin (MT1/MT2) and serotonin 5-HT2C receptor subtypes (II).
Ettaoussi M; Pérès B; Errazani A; Boutin JA; Caignard DH; Delagrange P; Melnyk P; Berthelot P; Yous S
Eur J Med Chem; 2015 Jan; 90():822-33. PubMed ID: 25528336
[TBL] [Abstract][Full Text] [Related]
14. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
Stein RM; Kang HJ; McCorvy JD; Glatfelter GC; Jones AJ; Che T; Slocum S; Huang XP; Savych O; Moroz YS; Stauch B; Johansson LC; Cherezov V; Kenakin T; Irwin JJ; Shoichet BK; Roth BL; Dubocovich ML
Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
[TBL] [Abstract][Full Text] [Related]
15. [Sites and mechanisms of action of melatonin in mammals: the MT1 and MT2 receptors].
Schuster C
J Soc Biol; 2007; 201(1):85-96. PubMed ID: 17762828
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening assay for new ligands at human melatonin receptors.
Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
[TBL] [Abstract][Full Text] [Related]
17. Melatonin receptor ligands: A pharmaco-chemical perspective.
Boutin JA; Witt-Enderby PA; Sotriffer C; Zlotos DP
J Pineal Res; 2020 Oct; 69(3):e12672. PubMed ID: 32531076
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new melatoninergic hexahydroindenopyridines.
Moreno L; Berenguer I; Diaz A; Marín P; Párraga J; Caignard DH; Figadère B; Cabedo N; Cortes D
Bioorg Med Chem Lett; 2014 Aug; 24(15):3534-6. PubMed ID: 24930835
[TBL] [Abstract][Full Text] [Related]
19. Melatonin receptor heterodimerization in a photoreceptor-like cell line endogenously expressing melatonin receptors.
Sánchez-Bretaño A; Suen TC; Baba K; DeBruyne J; Tosini G
Mol Vis; 2019; 25():791-799. PubMed ID: 31819341
[TBL] [Abstract][Full Text] [Related]
20. Melatonin MT
Chen M; Cecon E; Karamitri A; Gao W; Gerbier R; Ahmad R; Jockers R
J Pineal Res; 2020 May; 68(4):e12641. PubMed ID: 32080899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]